In 2023, Lysenko and colleagues [27] demonstrated that the interruption of the interaction between CD47 and Sirp-α in an animal model of PV ameliorates the disease phenotype and that the anti-CD47 treatment resulted in the expansion of monocyte-derived macrophages and dendritic cells with phagocytic phenotype. This evidence concerns the gene SIRPA and acquired polycythemia vera.